Company intelligence / Profile preview
Yunovia Co., Ltd.
Seoul, Seoul, South Koreayunovia.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Yunovia is a clinical-stage biopharmaceutical company spun off from Ildong Pharmaceutical in November 2023. It focuses on developing innovative small molecule therapies for metabolic diseases, neurodegenerative disorders, gastrointestinal conditions, and other high unmet need areas. Its lead asset is an oral GLP‑1 receptor agonist for diabetes and obesity that has completed Phase 1 SAD studies with favorable safety/tolerability results and is now in Phase 1 MAD trials. Other pipeline assets are at various stages from preclinical to early clinical development.
- Therapeutic areas
- Metabolic DisordersEndocrinologyGastroenterologyOphthalmologyNeurology
- Modalities
- Small moleculesReceptor agonists/antagonistsFXR agonistCFTR activator/PDE4 inhibitor
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Engaged in discussions with global companies for outlicensing opportunities for its lead program(s).No major partnerships publicly announced yet.
Beyond the preview
Go deeper on Yunovia Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yunovia Co., Ltd..